Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2569-2575
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2569
Figure 1
Figure 1 Images of gastrointestinal stromal tumor using hematoxylin-eosin staining and immunohistochemical staining. A: Hematoxylin-eosin stain; B: DOG1 stain; C: Ki-67 stain; D: P53 stain; E: Epidermal growth factor receptor stain; F: Cyclooxygenase-2 stain.
Figure 2
Figure 2 Kaplan-Meier plots for predicting disease specific survival based on the modified National Institutes of Health consensus system (A), Ki-67 expression (B) and adjuvant imatinib therapy (C).